Current progress and mechanisms of bone metastasis in lung cancer: a narrative review

被引:72
作者
Wu, Shengyu [1 ,2 ]
Pan, Yue [1 ,2 ]
Mao, Yanyu [1 ,2 ]
Chen, Yu [3 ]
He, Yayi [1 ]
机构
[1] Tongji Univ, Shanghai Pulm Hosp, Dept Med Oncol, Shanghai, Peoples R China
[2] Tongji Univ, Med Sch, Shanghai, Peoples R China
[3] Shanghai Changzheng Hosp, Orthoped Dept, Spine Ctr, 415 Fengyang Rd, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
Lung cancer; bone metastasis; diagnosis methods; mechanism; treatment; CIRCULATING TUMOR-CELLS; QUALITY-OF-LIFE; ZOLEDRONIC ACID; OSTEOGENIC DIFFERENTIATION; E-CADHERIN; SURVIVAL; DIAGNOSIS; ADENOCARCINOMA; DENOSUMAB; CABOZANTINIB;
D O I
10.21037/tlcr-20-835
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer is a kind of malignant tumor with rapid progression and poor prognosis. Distant metastasis has been the main cause of mortality among lung cancer patients. Bone is one of the most common sites. Among all lung cancer patients with bone metastasis, most of them are osteolytic metastasis. Some serious clinical consequences like bone pain, pathological fractures, spinal instability, spinal cord compression and hypercalcemia occur as well. Since the severity of bone metastasis in lung cancer, it is undoubtedly necessary to know how lung cancer spread to bone, how can we diagnose it and how can we treat it. Here, we reviewed the process, passible mechanisms, diagnosis methods and current treatment of bone metastasis in lung cancer. We divided the process of bone metastasis in lung cancer into three steps: tumor invasion, tumor cell migration and invasion in bone tissue. It may be influenced by genetic factors, microenvironment and other adhesion-related factors. Imaging examination, laboratory examination, and pathological examination are used to diagnose lung cancer metastasis to bone. Surgery, radiotherapy, targeted therapy, bisphosphonate, radiation therapy and chemotherapy are the common clinical treatment methods currently. We also found some problems remained to be solved. For example, drugs for skeletal related events mainly target on osteoclasts at present, which increase the ratio of patients in osteoporosis and fractures in the long term. In all, this review provides the direction for future research on bone metastasis in lung cancer.
引用
收藏
页码:439 / 451
页数:13
相关论文
共 116 条
[61]   Metastatic dissemination patterns of different primary tumors to the spine and other bones [J].
Onken, Julia S. ;
Fekonja, Lucius S. ;
Wehowsky, Romy ;
Hubertus, Vanessa ;
Vajkoczy, Peter .
CLINICAL & EXPERIMENTAL METASTASIS, 2019, 36 (06) :493-498
[62]   Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases [J].
Otto, Sven ;
Pautke, Christoph ;
Van den Wyngaert, Tim ;
Niepel, Daniela ;
Schiodt, Morten .
CANCER TREATMENT REVIEWS, 2018, 69 :177-187
[63]   Considerations in the development of circulating tumor cell technology for clinical use [J].
Parkinson, David R. ;
Dracopoli, Nicholas ;
Petty, Brenda Gumbs ;
Compton, Carolyn ;
Cristofanilli, Massimo ;
Deisseroth, Albert ;
Hayes, Daniel F. ;
Kapke, Gordon ;
Kumar, Prasanna ;
Lee, Jerry S. H. ;
Liu, Minetta C. ;
McCormack, Robert ;
Mikulski, Stanislaw ;
Nagahara, Larry ;
Pantel, Klaus ;
Pearson-White, Sonia ;
Punnoose, Elizabeth A. ;
Roadcap, Lori T. ;
Schade, Andrew E. ;
Scher, Howard I. ;
Sigman, Caroline C. ;
Kelloff, Gary J. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
[64]   A causal role for E-cadherin in the transition from adenoma to carcinoma [J].
Perl, AK ;
Wilgenbus, P ;
Dahl, U ;
Semb, H ;
Christofori, G .
NATURE, 1998, 392 (6672) :190-193
[65]  
Pezzuto Aldo, 2019, Oncotarget, V10, P7071, DOI 10.18632/oncotarget.27378
[66]   An easy-to-use scoring system to estimate the survival of patients irradiated for bone metastases from lung cancer [J].
Rades, Dirk ;
Haus, Rapha ;
Janssen, Stefan ;
Schild, Steven E. .
TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) :1067-1073
[67]   Molecular Regulation of Bone Marrow Metastasis in Prostate and Breast Cancer [J].
Rahim, Fakher ;
Hajizamani, Saeideh ;
Mortaz, Esmaeil ;
Ahmadzadeh, Ahmad ;
Shahjahani, Mohammad ;
Shahrabi, Saeid ;
Saki, Najmaldin .
BONE MARROW RESEARCH, 2014,
[68]   Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study [J].
Raje, Noopur ;
Terpos, Evangelos ;
Willenbacher, Wolfgang ;
Shimizu, Kazuyuki ;
Garcia-Sanz, Ramon ;
Durie, Brian ;
Legiec, Wojciech ;
Krejci, Marta ;
Laribi, Kamel ;
Zhu, Li ;
Cheng, Paul ;
Warner, Douglas ;
Roodman, G. David .
LANCET ONCOLOGY, 2018, 19 (03) :370-381
[69]   Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases [J].
Renaud, Stephane ;
Falcoz, Pierre-Emmanuel ;
Schaeffer, Mickael ;
Guenot, Dominique ;
Romain, Benoit ;
Olland, Anne ;
Reeb, Jeremie ;
Santelmo, Nicola ;
Chenard, Marie-Pierre ;
Legrain, Michele ;
Voegeli, Anne-Claire ;
Beau-Faller, Michele ;
Massard, Gilbert .
BRITISH JOURNAL OF CANCER, 2015, 113 (08) :1206-1215
[70]   The Uncovered Role of Immune Cells and NK Cells in the Regulation of Bone Metastasis [J].
Roato, Ilaria ;
Vitale, Massimo .
FRONTIERS IN ENDOCRINOLOGY, 2019, 10